Investors Face December 7 Deadline in Chemours Class Action Lawsuit

Overview of the Class Action Lawsuit

ClaimsFiler has issued a notice reminding investors who incurred losses exceeding $100,000 to apply as lead plaintiffs in a securities class action lawsuit against The Chemours Company (NYSE: CC). The deadline to file these applications is December 7, 2026. The lawsuit, pending in the United States District Court for the District of Delaware, concerns investors who purchased Chemours securities between February 20, 2026, and August 4, 2026.

Allegations Against The Chemours Company

The lawsuit alleges that Chemours and certain of its executives failed to disclose material information during the specified period, purportedly violating federal securities laws. The legal action follows a downward revision of the company's financial guidance.

• On August 4, 2026, Chemours announced its second-quarter financial results.
• The company reduced its full-year adjusted EBITDA guidance to $775–$825 million, down from the previous forecast of $800–$900 million.
• CEO Denise Dignam cited an oversupplied channel resulting from aftermarket inventory buildup.
• CFO Shane Hostetter noted approximately $65 million in aftermarket sales that likely should have been allocated to the current year.

Following these disclosures, Chemours shares fell $3.34, or 18.63%, to close at $14.59 on August 5, 2026.

Next Steps for Investors

The case is identified as *Darcy v. The Chemours Company, et al.*, No. 26-cv-01299. Investors interested in their legal options or seeking to evaluate their claims can visit the ClaimsFiler website or contact the law firm Kahn Swick & Foti, LLC. The service allows investors to register for case updates and monitor potential class action settlements.